{"organizations": [], "uuid": "6c7e79b88e9701fb4bd543b007716236bab3540c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-sabra-health-care-reit-qtrly-adjus/brief-sabra-health-care-reit-qtrly-adjusted-ffo-per-share-0-66-idUSL8N1QB82G", "country": "US", "domain_rank": 408, "title": "BRIEF-Sabra Health Care REIT Qtrly Adjusted FFO Per Share $0.66", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-22T00:55:00.000+02:00", "replies_count": 0, "uuid": "6c7e79b88e9701fb4bd543b007716236bab3540c"}, "author": "", "url": "https://www.reuters.com/article/brief-sabra-health-care-reit-qtrly-adjus/brief-sabra-health-care-reit-qtrly-adjusted-ffo-per-share-0-66-idUSL8N1QB82G", "ord_in_thread": 0, "title": "BRIEF-Sabra Health Care REIT Qtrly Adjusted FFO Per Share $0.66", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-sabra health care", "sentiment": "negative"}, {"name": "ccp", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters) - sabra health care", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 21 (Reuters) - Sabra Health Care REIT Inc:\n* SABRA REPORTS FOURTH QUARTER 2017 RESULTS; CLOSES ON ENLIVANT INVESTMENTS; PROVIDES UPDATE ON CCP MERGER EXECUTION; PROVIDES UPDATE ON GENESIS EXODUS; UPDATES 2018 EARNINGS GUIDANCE\n* Q4 ADJUSTED FFO PER SHARE $0.60 * Q4 FFO PER SHARE VIEW $0.67 -- THOMSON REUTERS I/B/E/S\n* QTRLY FFO PER SHARE $0.60 * QTRLY NORMALIZED FFO PER SHARE $0.66 * SEES ‍2018 FFO SHR $2.31 TO $2.39; AFFO SHR $2.15 TO $2.23 AND NORMALIZED AFFO SHR $2.28 TO $2.36​\n* FY2018 FFO SHR VIEW $2.49 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-22T00:55:00.000+02:00", "crawled": "2018-02-22T01:04:09.004+02:00", "highlightTitle": ""}